Trials / Completed
CompletedNCT01958866
Study of Efficacy and Safety of Tinospora Crispa-extract Product Compared With the Acetaminophen
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hypothesis: Tinospora Crispa-extract Product can reduce pyretic similar to acetaminophen. This study aims to investigate the efficacy and safety of Tinospora Crispa-extract product compared with the acetaminophen. Total of 96 patients with body temperature between 37.8-38.5 without any signs of infections will be enrolled in this study. Patients will be randomly divided into 3 groups: First group will receive acetaminophen 1000 mg every 6 hr, Second group will receive Tinospora Crispa-extract Product 2000 mg twice daily and the third group will receive placebo twice daily.
Detailed description
Patients in each group will be monitored for body temperature at baseline (at the time of enrollment) and at 1, 2, 4, 6, 8, 24 h after receiving the tested material.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tinospora Crispa-extract Product | |
| DRUG | Acetaminophen | |
| OTHER | Placebo |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2013-10-09
- Last updated
- 2015-03-11
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01958866. Inclusion in this directory is not an endorsement.